المؤلفون: Boiko AS, Pozhidaev IV, Paderina DZ, Bocharova AV, Mednova IA, Fedorenko OY, Kornetova EG, Loonen AJM, Semke AV, Bokhan NA, Ivanova SA

المصدر: Pharmacogenomics and Personalized Medicine, Vol Volume 14, Pp 1123-1131 (2021)

مصطلحات موضوعية: schizophrenia, gene polymorphism, body weight, waist circumference, fat mass and obesity associated gene, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/search-for-possible-associations-of-fto-gene-polymorphic-variants-with-peer-reviewed-fulltext-article-PGPMTest; https://doaj.org/toc/1178-7066Test

الوصول الحر: https://doaj.org/article/681ff755b9ad4ad0a2daade7eb21631aTest

المؤلفون: Pozhidaev IV, Boiko AS, Loonen AJM, Paderina DZ, Fedorenko OY, Tenin G, Kornetova EG, Semke AV, Bokhan NA, Wilffert B, Ivanova SA

المصدر: The Application of Clinical Genetics, Vol Volume 13, Pp 97-105 (2020)

مصطلحات موضوعية: schizophrenia, suicide, tardive dyskinesia, pacsin3, chrm4, gene polymorphism, Medicine (General), R5-920, Genetics, QH426-470

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/association-of-cholinergic-muscarinic-m4-receptor-gene-polymorphism-wi-peer-reviewed-article-TACGTest; https://doaj.org/toc/1178-704XTest

الوصول الحر: https://doaj.org/article/39429ef3f13f4e2dae2a6dd1fd1cd15aTest

المؤلفون: Kotova Svetlana, Pozhidaev Evgeny, Samagin Sergey, Kesaev Vladimir, Mayorova Aleksandra

المصدر: EPJ Web of Conferences, Vol 220, p 01005 (2019)

مصطلحات موضوعية: Physics, QC1-999

وصف الملف: electronic resource

العلاقة: https://www.epj-conferences.org/articles/epjconf/pdf/2019/25/epjconf_iwqo18_01005.pdfTest; https://doaj.org/toc/2100-014XTest

الوصول الحر: https://doaj.org/article/b28346c7d0294e9f8ac909a95a19fcb1Test

المؤلفون: Kiselev Alexei D., Kesaev Vladimir V., Pozhidaev Evgeny P.

المصدر: EPJ Web of Conferences, Vol 161, p 02010 (2017)

مصطلحات موضوعية: Physics, QC1-999

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2100-014XTest

الوصول الحر: https://doaj.org/article/c0ae680dbde74b4b914ef9fde2f0e021Test

المؤلفون: Kotova Svetlana, Mayorova Aleksandra, Pozhidaev Evgeny, Samagin Sergey

المصدر: EPJ Web of Conferences, Vol 161, p 01007 (2017)

مصطلحات موضوعية: Physics, QC1-999

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2100-014XTest

الوصول الحر: https://doaj.org/article/3f9e3a6f0c714527a166f708a80755cdTest

المؤلفون: A. V. Gordeev, E. A. Galushko, E. V. Matyanova, E. V. Pozhidaev, E. G. Zotkin, A. M. Lila, А. В. Гордеев, Е. А. Галушко, Е. В. Матьянова, Е. В. Пожидаев, Е. Г. Зоткин, А. М. Лила

المساهمون: The work was carried out within the framework of the government task on scientific topic №1021051503137-7., Работа выполнена в рамках государственного задания по теме №1021051503137-7.

المصدر: Modern Rheumatology Journal; Том 18, № 2 (2024); 51–55 ; Современная ревматология; Том 18, № 2 (2024); 51–55 ; 2310-158X ; 1996-7012

مصطلحات موضوعية: почечно-легочный синдром, interstitial lung disease, chronic kidney disease, multimorbidity, renal-pulmonary syndrome, интерстициальное заболевание легких, хроническая болезнь почек, мультиморбидность

وصف الملف: application/pdf

العلاقة: https://mrj.ima-press.net/mrj/article/view/1561/1457Test; Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016 Oct 22; 388(10055):2023-2038. doi:10.1016/S01406736(16)30173-8. Epub 2016 May 3.; Yunt ZX, Solomon JJ. Lung disease inrheumatoid arthritis. Rheum Dis Clin North Am. 2015 May;41(2):225-36. doi:10.1016/j.rdc.2014.12.004. Epub 2015 Feb 3.; Esposito AJ, Chu SG, Madan R, et al.Thoracic manifestations of rheumatoid arthritis. Clin Chest Med. 2019 Sep;40(3):545-560. doi:10.1016/j.ccm.2019.05.003. Epub 2019 Jul 6.; Насонов ЕЛ, Ананьева ЛП, Авдеев СН.Интерстициальные заболевания легких при ревматоидном артрите: мультидисциплинарная проблема ревматологии и пульмонологии. Научно-практическая ревматология. 2022;60(6):517-534.; Kelly C, Emery P, Dieude P. Current issuesin rheumatoid arthritis related interstitial lung disease (RA-ILD). Lancet Rheumatol. 2021 Nov;3(11):e798-e807. doi:10.1016/S2665-9913(21)00250-2; Kadura S, Raghu G. Rheumatoid arthritisinterstitial lung disease: Manifestations and current concepts in pathogenesis and management. Eur Respir Rev. 2021 Jun 23;30(160): 210011. doi:10.1183/16000617.0011-2021. Print 2021 Jun 30.; Wang D, Zhang J, Lau J, et al. Mechanismsof lung disease Development in rheumatoid arthritis. Nat Rev Rheumatol. 2019 Oct;15(10): 581-596. doi:10.1038/s41584-019-0275-x. Epub 2019 Aug 27; Гордеев АВ, Галушко ЕА, Матьянова ЕВи др. Особенности фармакотерапии больных ревматоидным артритом, ассоциированным с интерстициальным заболеванием легких. Современная ревматология. 2024;18(1): 54-61. doi:10.14412/1996-7012-2024-1-54-61.; Said A, Desai C, Lerma EV. Chronic kidney disease. Dis Mon. 2015 Sep;61(9):374-7. doi:10.1016/j.disamonth.2015.08.001. Epub 2015 Sep 2.; Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study. Arthritis Rheum. 2010 Jun;62(6):1583-91. doi:10.1002/art.27405.; Juge PA, Granger B, Debray MP, et al. A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease. Ann Rheum Dis. 2022 Nov;74(11):1755-1765.; Sparks JA, He X, Huang J, et al. Rheumatoid arthritis disease activity predicting inciСовременная ревматология. 2024;18(2):51–55 dent clinically apparent rheumatoid arthritisassociated interstitial lung disease: A prospective cohort study. Arthritis Rheumatol. 2019 Sep;71(9):1472-1482. doi:10.1002/art.40904. Epub 2019 Aug 4.; Cavagna L. The multifaceted aspects ofinterstitial lung disease in rheumatoid arthritis. Biomed Res Int. 2013:2013:759760. doi:10.1155/2013/759760. Epub 2013 Sep 25.; Doyle TJ, Lee JS, Dellaripa PF, et al. A roadmap to promote clinical and translational research in rheumatoid arthritis associated interstitial lung disease. Chest. 2014 Mar 1; 145(3):454-463. doi:10.1378/chest.13-2408.; Гордеев АВ, Галушко ЕА, Савушкина НМи др. Оценка мультиморбидного профиля (CIRS) при ревматоидном артрите. Первые результаты. Современная ревматология. 2019;13(3):10-16. doi: 10/14412/1996-7012-2019-3-10-16; Hall JE, do Carmo JM, da Silva AA, et al. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019 Jun; 15(6):367-385. doi:10.1038/s41581-0190145-4.; Zoccali C, Vanholder R, Ziad A, et al. The systemic nature of CKD. Nat Rev Nephrol. 2017 Jun;13(6):344-358. doi:10.1038/nrneph.2017.52. Epub 2017 Apr 24.; Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol. 2021 Jan;22(1):10-18. doi:10.1038/s41590-02000816-x. Epub 2020 Nov 30.; Zhang C, Merana GR, Harris-Tryon T,Scharschmidt T. Skin immunity: dissecting the complex biology of our body’s outer barrier. Mucosal Immunol. 2022 Apr;15(4): 551-561. doi:10.1038/s41385-022-00505-y. Epub 2022 Mar 31.; Drummond GR, Vinh A, Guzik TJ, Sobey CG. Immune mechanisms of hypertension. Nat Rev Immunol. 2019 Aug;19(8): 517-532. doi:10.1038/s41577-019-0160-5.; Wijsenbeek M, Cottin V. Spectrum of Fibrotic Lung Diseases. N Engl J Med. 2020 Sep 3;383(10):958-968. doi:10.1056/NEJMra2005230.; Li L, Haiyan F, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol. 2022 Sep;18(9): 545-557. doi:10.1038/s41581-022-00590-z. Epub 2022 Jul 4.; Speer T, Dimmeler S, Schunk SJ, et al.Targeting innate immunity-driven inflammation in CKD and cardiovascular disease. Nat Rev Nephrol. 2022 Dec;18(12):762-778. doi:10.1038/s41581-022-00621-9. Epub 2022 Sep 5.; Гордеев АВ, Галушко ЕА, Савушкина НМ. Роль ангиотензинов в патогенезе воспалительных заболеваний суставов. Терапевтический архив. 2021;93(5):635-639.; Navaneethan SD, Mandayam S, Arrigain S, et al. Obstructive and restrictive lung function measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007–2012. Am J Kidney Dis. 2016 Sep;68(3): 414-21. doi:10.1053/j.ajkd.2016.03.415. Epub 2016 Apr 27.; https://mrj.ima-press.net/mrj/article/view/1561Test

الإتاحة: https://doi.org/10.14412/1996-7012-2024-2-51-55Test
https://doi.org/10.1016/S01406736Test(16)30173-8
https://doi.org/10.1016/j.rdc.2014.12.004Test
https://doi.org/10.1016/j.ccm.2019.05.003Test
https://doi.org/10.1016/S2665-9913Test(21)00250-2
https://doi.org/10.1183/16000617.0011-2021Test
https://doi.org/10.1038/s41584-019-0275-xTest
https://doi.org/10.14412/1996-7012-2024-1-54-61Test
https://doi.org/10.1016/j.disamonth.2015.08.001Test
https://doi.org/10.1002/art.27405Test

المؤلفون: A. V. Gordeev, E. A. Galushko, E. V. Matyanova, E. V. Pozhidaev, E. G. Zotkin, A. M. Lila, А. В. Гордеев, Е. А. Галушко, Е. В. Матьянова, Е. В. Пожидаев, Е. Г. Зоткин, А. М. Лила

المصدر: Modern Rheumatology Journal; Том 18, № 1 (2024); 54-61 ; Современная ревматология; Том 18, № 1 (2024); 54-61 ; 2310-158X ; 1996-7012

مصطلحات موضوعية: фармакотерапия, interstitial lung disease, multimorbidity, disease-modifying antirheumatic drugs, biologic disease-modifying antirheumatic drugs, glucocorticoids, pharmacotherapy, интерстициальное заболевание легких, мультиморбидность, базисные противовоспалительные препараты, генно-инженерные биологические препараты, глюкокортикоиды

وصف الملف: application/pdf

العلاقة: https://mrj.ima-press.net/mrj/article/view/1531/1438Test; Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016 Oct 22; 388(10055):2023-2038. doi:10.1016/S0140-6736(16)30173-8. Epub 2016 May 3.; Finckh A, Gilbert B, Hodkinson B, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022 Oct;18(10):591-602. doi:10.1038/s41584-022-00827-y. Epub 2022 Sep 6.; Smolen JS, Aletaha D, Bijlsma JW et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010 Apr;69(4):631-7. doi:10.1136/ard.2009.123919. Epub 2010 Mar 9.; Wang D, Zhang J, Lau J, et al. Mechanisms of lung disease Development in rheumatoid arthritis. Nat Rev Rheumatol. 2019 Oct;15(10): 581-596. doi:10.1038/s41584-019-0275-x. Epub 2019 Aug 27.; Hyldgaard C, Ellingsen T, Hilberg O. Rheumatoid arthritis-associated interstitial lung disease: clinical characteristics and predictors of mortality. Respiration. 2019;98(5): 455-460. doi:10.1159/000502551. Epub 2019 Oct 9.; Spagnolo P, Lee JS, Sverzellati N. The lung in rheumatoid arthritis: focus on interstitial lung disease. Arthritis Rheumatol. 2018 Oct;70(10):1544-1554. doi:10.1002/art.40574. Epub 2018 Sep 4.; Sparks JA, Jin Y, Cho SK. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology (Oxford). 2021 Aug 2; 60(8):3689-3698. doi:10.1093/rheumatology/keaa836.; Samhouri BF, Vassallo R, Achenbach SJ. Incidence, risk factors, and mortality of clinical and subclinical rheumatoid arthritis-associated interstitial lung disease: a populationbased cohort. Arthritis Care Res (Hoboken). 2022 Dec;74(12):2042-2049. doi:10.1002/ acr.24856. Epub 2022 Aug 10.; Насонов ЕЛ, Ананьева ЛП, Авдеев СН. Интерстициальные заболевания легких при ревматоидном артрите: мультидисциплинарная проблема ревматологии и пульмонологии. Научно-практическая ревматология. 2022;60(6):1.; Fischer A, Distler J. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases. Clin Rheumatol. 2019 Oct;38(10):2673-2681. doi:10.1007/s10067-019-04720-0. Epub 2019 Aug 19.; Diesler R, Cottin V. Pulmonary fibrosis associated with rheumatoid arthritis: From pathophysiology to treatment strategies. Expert Rev Respir Med. 2022 May;16(5):541-553. doi:10.1080/17476348.2022.2089116. Epub 2022 Jun 29.; Akiyama M, Kaneko Y. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev. 2022 May;21(5): 103056. doi:10.1016/j.autrev.2022.103056. Epub 2022 Feb 1.; Kelly C, Emery P, Dieude P. Current issues in rheumatoid arthritis related interstitial lung disease (RA-ILD). Lancet Rheumatol. 2021 Nov;3(11):e798-e807. doi:10.1016/S2665-9913(21)00250-2.; England BR, Hershberger D. Management issues in rheumatoid arthritis-associated interstitial lung disease. Curr Opin Rheumatol. 2020 May;32(3):255-263. doi:10.1097/BOR.0000000000000703.; Fragoulis GE, Nikiphorou E, Larsen J, et al. Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment. Front Med (Lausanne). 2019 Oct 23:6:238. doi:10.3389/fmed.2019.00238. eCollection 2019.; Krüger K. Interstitial lung disease (ILD) – when and how to treat. Z Rheumatol. 2020 Oct;79(8):780-781. doi:10.1007/s00393-020-00829-9.; Albrecht K, Strangfeld A, Marschall U. Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020. RMD Open. 2023 Jan;9(1):e002777. doi:10.1136/rmdopen-2022-002777.; Huang Y, Lin W, Chen Z, et al. Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: Angel or demon? Drug Des Devel Ther. 2019 Jul 1;13: 2111-2125. doi:10.2147/DDDT.S204730. eCollection 2019.; Гордеев АВ, Галушко ЕА, Савушкина НМ и др. Оценка мультиморбидного профиля (CIRS) при ревматоидном артрите. Первые результаты. Современная ревматология. 2019;13(3):10-16. doi: 10/14412/1996-7012-2019-3-10-16; Гордеев АВ, Матьянова ЕВ, Олюнин ЮА и др. Труднолечимый ревматоидный артрит (difficult-to-treat RA) в клинической практике ревматологического стационара. Первый взгляд. Современная ревматология. 2022;16(2):13-20. doi:10.14412/19967012-2022-2-13-20; Насонов ЕЛ. Фармакотерапия ревматоидного артрита: российские и международные рекомендации. Научно-практическая ревматология. 2016;54(5): 557-571.; Nagy G, Roodenrijs NMT, Welsing PM, et al. EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis. 2021 Jan;80(1):31-5. doi:10.1136/annrheumdis 2020-217344.; Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992 Mar;41(3):237-48. doi:10.1016/0165-1781(92)90005; Kadura S, Raghu G. Rheumatoid arthritis-interstitial lung disease: Manifestations and current concepts in pathogenesis and management. Eur Respir Rev. 2021 Jun 23; 30(160):210011. doi:10.1183/16000617.0011-2021. Print 2021 Jun 30.; Chen J, Chen Y, Liu D, et al. Predictors of long term prognosis in rheumatoid arthritis related interstitial lung disease. Sci Rep. 2022 Jun 8;12(1):9469. doi:10.1038/s41598-022-13474-w.; Zhang Y, Li H, Wu N, et al. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol. 2017 Apr;36(4):817-823. doi:10.1007/s10067-017-3561-5. Epub 2017 Feb 12.; Kronzer VL, Huang W, Dellaripa PF, et al. Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease. J Rheumatol. 2021 May;48(5): 656-663. doi:10.3899/jrheum.200863. Epub 2020 Nov 15.; Li L, Liu R, Zhang Y, et al. A retrospective study on the predictive implications of clinical characteristic and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol. 2020 May;39(5):1457-1470. doi:10.1007/s10067-019-04846-1. Epub 2019 Dec 19.; Kiely P, Busby AD, Nikiphorou E, et al. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open. 2019 May 5;9(5):e028466. doi:10.1136/bmjopen-2018-028466.; Conway R, Low C, Coughlan RJ, et al. Leflunomide use and risk of lung disease in rheumatoid arthritis: A systematic literature review and metaanalysis of randomized controlled trials. J Rheumatol. 2016 May;43(5): 855-60. doi:10.3899/jrheum.150674. Epub 2016 Mar 15.; Cassone G, Manfredi A, Vacchi C, et al. Treatment of rheumatoid arthritis-associated interstitial lung disease: Lights and shadows. J Clin Med. 2020 Apr 10;9(4):1082. doi:10.3390/jcm9041082.; Hadjinicolaou AV, Nisar MK, Bhagat S, et al. Non-infectious pulmonary complications of newer biological agents for rheumatic diseases – A systematic literature review. Rheumatology (Oxford). 2011 Dec;50(12): 2297-305. doi:10.1093/rheumatology/ker289. Epub 2011 Oct 22.; Nelson D, McLaughlin M, Östör A. Abatacept and its impact on interstitial lung disease: A systematic literature review. Ann Rheumatic Dis. 2015;74:1015. doi:10.1136/annrheumdis-2015-eular.2004; Tardella M, Di Carlo M, Carotti M, et al. A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease. Inflammopharmacology. 2022 Jun;30(3):705-712. doi:10.1007/s10787-022-00936-w. Epub 2022 Apr 24.; https://mrj.ima-press.net/mrj/article/view/1531Test

الإتاحة: https://doi.org/10.14412/1996-7012-2024-1-54-61Test
https://doi.org/10.1016/S0140-6736Test(16)30173-8
https://doi.org/10.1038/s41584-022-00827-yTest
https://doi.org/10.1136/ard.2009.123919Test
https://doi.org/10.1038/s41584-019-0275-xTest
https://doi.org/10.1159/000502551Test
https://doi.org/10.1002/art.40574Test
https://doi.org/10.1093/rheumatology/keaa836Test
https://doi.org/10.1007/s10067-019-04720-0Test
https://doi.org/10.1080/17476348.2022.2089116Test

المؤلفون: Kaygorodov, Ivan, Popov, Yury, Pozhidaev, Alexandr

مصطلحات موضوعية: Mathematics - Rings and Algebras

الوصول الحر: http://arxiv.org/abs/1811.00985Test

المؤلفون: Tyutnev, Andrey, Saenko, Vladimir, Mullakhmetov, Ilshat, Pozhidaev, Evgenii

المصدر: Journal of Applied Physics; 9/7/2023, Vol. 134 Issue 9, p1-10, 10p

مصطلحات موضوعية: LOW temperatures, SPACE charge, CHARGE carriers, POLYMERS, ELECTRON beams

المؤلفون: Benito, Pilar, Gubarev, Vsevolod, Pozhidaev, Alexander

المصدر: Mediterranean Journal of Mathematics, vol. 15, Article number: 189 (2018)

مصطلحات موضوعية: Mathematics - Rings and Algebras, 16T25, 17A45, 17C50

الوصول الحر: http://arxiv.org/abs/1801.07037Test